Ovarian tumors of low malignant potential: A retrospective study of 234 patients

International Journal of Gynecological Cancer

Volumn 7, Issue 3, 1997, Pages 218-226

  Sykes, P H ^a,b   Quinn, M A ^a   Rome, R M ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b Christchurch Womens Hospital   (New Zealand)

Author keywords

Low malignant potential; Ovary; Tumor

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVARY TUMOR; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; SECOND CANCER;

EID: 0030790718     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00445.x     Document Type: Article

References (35)

1. Harlow BL, Weiss NS, Lofton S. Epidemiology of borderline ovarian tumors. J Natl Cancer Inst 1987; 78 (Suppl. 1): 71-4.
2. Serov SF, Scully RE, Sobin LH. The histological typing of ovarian tumors. In: International Histological Classification of Tumors No 9. Geneva: WHO, 1973: 17.
3. Koern J, Troupe CG, Abeler VM. A retrospective study of 370 borderline tumours of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. Cancer 1993; 71: 1810-20.
4. Russell P, Merkur H. Proliferating ovarian 'epithelial' tumours: a clinico-pathological analysis of 144 cases. Aust NZJ Obstet Gynecol 1979; 19: 45-51.
5. Bostwick DG, Tazelaar HD, Ballon SB, et al. Ovarian epithelial tumours of borderline malignancy. Cancer 1986; 58: 2052-65.
6. Folke Pettersson. Annual Report on the Results of Treatment in Gynaecological Cancer, Vol 22. Stockholm FIGO 1994.
7. Kliman L, Rome RM, Fortune DW. Low malignant potential tumours of the ovary: a study of 76 cases. Obstet Gynecol 1986; 68: 338-44.
8. Kaern J, Troupe CG, Kristensen GB, et al. DNA ploidy: the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 1993; 3: 349-58.
9. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Cancer 1988; 62: 2212-22.
10. Kurman RJ, Trimble CL. The behavior of serous tumors of low malignant potential. Int J Gynecol Pathol 1993; 12: 120-7.
11. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Am J Surg Pathol 1995; 19: 1390-408.
12. Atkin NB. The clinical usefulness of determining ploidy patterns in human tumors as measured by slide-based Feulgin microspectrophotometry. Analy Quantit Cytol Histol 1991; 13: 75-9.
13. Trimble C, Trimble E. Management of epithelial ovarian tumours of low malignant potential. Gynecol Oncol 1994; 55: S52-S61.
14. Giles G, Farrugia H, Silver B, Staples M. Cancer in Victoria, 1982-87. Victorian Cancer Registry publication 1992: 62-3.
15. Harris R, Whitmore A, Intyre J. Characteristics relating to ovarian cancer risk; colaborative analysis of 12 US case control studies. Am J Epidemiol. 1992; 136: 1204-11.
16. Rice LW, Lage JM, Berkowitz RS, et al. Preoperative serum CA125 levels in borderline tumors of the ovary. Gynecol Oncol 1992; 46: 226-9.
17. Nakashima N, Nagasaka T, Oiwa N, et al. Ovarian epithelial tumours of borderline malignancy in Japan. Gynecol Oncology 1990; 38: 90-8.
18. Seidman JD, Elsayed AM, Sobin LH, et al. Association of mucinous tumours of the ovary and appendix. Am J Surg Pathol 1993; 17: 22-34.
19. Yazigi R, Sandstad J, Munoz AK. Primary staging in ovarian tumours of low malignant potential. Gynecol Oncol 1988; 31: 402-8.
20. Helewa ME, Krepart GV, Lotocki R. Staging laparotomy in early epithelial ovarian cancer. Am J Obstet Gynecol 1986; 154 (Suppl. 2): 282-6.
21. Robinson WR, Curtin JP, Morrow CP. Operative staging and conservative surgery in the management of low malignant potential ovarian tumours. Int J Gynecol Cancer 1992; 2: 113-18.
22. Hopkins MP, Morley GW. The second-look operation and surgical reexploration in ovarian tumor of low malignant potential. Obstet Gynecol 1989; 74: 375-8.
23. Rutgers JR, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. Cancer 1988; 61: 340-8.
24. DiRe F, Paladini D, Fontanelli R, et al. Surgical staging for epithelial ovarian tumours of low malignant potential. Int J Gynecol Cancer 1994; 4: 310-14.
25. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990; 65: 578-85.
26. Michael H, Roth LM. Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer 1986; 57: 1240-7.
27. Twaalfhoven FC, Peters AA, Trimbos JB, et al. The accuracy of frozen section diagnosis of ovarian tumors. Gynecol Oncol 1991; 41: 189-92.
28. Tazelaar HD, Bostwick DG, Ballon SC, et al Conservative treatment of borderline ovarian tumours. Obstet Gynecol 1985; 66: 417-22.
29. Lim-Tan SK, Cajigas HE, Scully RE. Ovarian cystectomy for serous borderline tumours: a follow-up study of 35 cases. Obstet Gynecol 1988; 72: 775-81.
30. Werthiem I, Fleischhacker D, McLachlin CM, et al. Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol 1994; 84: 17-21.
31. Bell DA, Scully RE. Benign and borderline clear cell adenofibromas of the ovary. Cancer 1985; 56: 2922-31.
32. Genadry R, Poliakoff S, Rotmensch J, et al. Primary papillary neoplasia. Obstet Gynecol 1981; 58: 730-4.
33. Younessi M, Crickard K, Celikand C, Younessi S. Borderline epithelial tumors of the ovary. O & G Survey 1989; 43: 435-44.
34. Sutton GP, Bundy BN, Omura GA, et al. Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy. Gynecol Oncol 1991; 41: 230-3.
35. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion, a report of 21 cases: Hum Pathol 1990; 21: 397-403.